Respiratory pathology in a patient with muscular dystrophy

1 Astejada M, Malicdan MC, Nishino I. Muscular dystrophies. International­ Encyclopedia­ of­ Public­ Health. 2017: 183–192. doi:10.1016/B978-0-12-803678-5.00297-6. Search in Google Scholar

2 Klimchak AC, Szabo SM, Qian C, Popoff E, Iannaccone S, Gooch KL. Characterizing demographics, comorbidities, and costs of care among populations with Duchenne muscular dystrophy with medicaid and commercial coverage. Journal of Managed Care and Specialty Pharmacy. 2021;27(10): 1426–1437. doi:10.18553/jmcp.2021.27.10.1426. Search in Google Scholar

3 Broomfield J, Hill M, Guglieri M, Crowther M, Abrams K. Life expectancy in Duchenne muscular dystrophy. Neurology. 2021;97(23): e2304–e2314. doi:10.1212/WNL.0000000000012910. Search in Google Scholar

4 Updated care guidelines for DMD – part 3 – European reference network – Euro-NMD. European Reference Network EURONMD. Available from: https://ern-euro-nmd.eu/publication/updated-care-guidelines-for-dmd-part-3/ [Accessed 17th May 2022]. Search in Google Scholar

5 Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology. 2018;17(4): 347–361. doi:10.1016/S1474-4422(18)30025-5. Search in Google Scholar

6 LoMauro A, D’Angelo MG, Aliverti A. Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Therapeutics and Clinical Risk Management. 2015;11: 1475–1488. doi:10.2147/TCRM.S55889. Search in Google Scholar

7 Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurology. 2010;9: 177–189. doi:10.1016/S1474-4422(09)70272-8. Search in Google Scholar

8 Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscular Disorders. 2002;12(10): 926–929. doi:10.1016/s0960-8966(02)00140-2. Search in Google Scholar

9 Simonds AK, Muntoni F, Heather S, Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax. 1998;53(11): 949–952. doi:10.1136/thx.53.11.949. Search in Google Scholar

10 Bach JR, Martinez D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respiratory Care. 2011;56(6): 744–750. doi:10.4187/respcare.00831. Search in Google Scholar

11 Ripolone M, Velardo D, Mondello S, Zanotti S, Magri F, Minuti E, et al. Muscle histological changes in a large cohort of patients affected with Becker muscular dystrophy. Acta Neuropathologica Communications. 2022;10(1): 48. doi:10.1186/s40478-022-01354-3. Search in Google Scholar

12 Dittrich S, Graf E, Trollmann R, Neudorf U, Schara U, Heilmann A, et al. Effect and safety of treatment with ACE- inhibitor enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy – a randomized, double-blind, placebo-controlled trial. Orphanet Journal of Rare Diseases. 2019;14(1): 105. doi:10.1186/s13023-019-1066-9. Search in Google Scholar

13 Hoque R. Sleep-disordered breathing in Duchenne muscular dystrophy: an assessment of the literature. Journal of Clinical Sleep Medicine. 2016;12(06): 905–911. doi:10.5664/jcsm.5898. Search in Google Scholar

14 Emery AE. The muscular dystrophies. The Lancet. 2002;359(9307): 687–695. doi:10.1016/s0140-6736(02)07815-7. Search in Google Scholar

15 Filippo TD, Parisi L, Roccella M. Psychological aspects in children affected by Duchenne de boulogne muscular dystrophy. Mental­Illness. 2012;4(1): 21–24. doi:10.4081/mi.2012.e5. Search in Google Scholar

16 Colvin MK, Poysky J, Kinnett K, Damiani M, Gibbons M, Hoskin J, et al. Psychosocial management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Suppl 2): S99–S109. doi:10.1542/peds.2018-0333l. Search in Google Scholar

17 Sadasivan A, Warrier MG, Polavarapu K, Preethish-Kumar V, Nair MG, Keerthipriya M, et al. Palliative care in Duchenne muscular dystrophy: a study on parents’ understanding. Indian­Journal of Palliative Care. 2021;27(1): 146–151. doi:10.4103/ijpc. ijpc_259_20. Search in Google Scholar

18 Bach JR. Noninvasive respiratory management of patients with neuromuscular disease. Annals of Rehabilitation Medicine. 2017;41(4): 519–538. doi:10.5535/arm.2017.41.4.519. Search in Google Scholar

19 Epure DA-M, Vladâcenco OA. Boli neuromusculare. In: Teleanu RI (ed.) Esențialul­ în­ neurologia­ pediatrică. 1st ed. Bucureşti: Editura Universitară “Carol Davila” Bucureşti a Universităţii de Medicină şi Farmacie “Carol Davila”; 2022. p. 179–190. Search in Google Scholar